Eagle Pharmaceuticals, Inc. Business Finance Contracts & Agreements
15 Contracts & Agreements
- Credit Agreements (3 contracts)
- Investor Rights Agreements (1)
- Loan Agreements (1)
- Purchase Agreements (3)
- Shareholders Agreements (2)
- Stock Agreements (5)
- Second Amendment to Third Amended and Restated Credit Agreement, among Eagle Pharmaceuticals, Inc., as borrower, JPMorgan Chase Bank, N.A., as administrative agent, and the... (Filed With SEC on March 1, 2024)
- Limited Waiver and First Amendment to Third Amended and Restated Credit Agreement, among Eagle Pharmaceuticals, Inc., as borrower, JPMorgan Chase Bank, N.A., as administrative... (Filed With SEC on January 16, 2024)
- Security Purchase Option Agreement, by and between the Registrant, Enalare Therapeutics Inc. and the other parties thereto, dated August 8, 2022 (Filed With SEC on August 9, 2022)
- Securities Purchase Agreement, by and between the Registrant and Enalare Therapeutics Inc., dated August 8, 2022 (Filed With SEC on August 9, 2022)
- Guaranty Agreement to Loan Agreement, by and among the Registrant, Acacia Pharma Limited and Cosmo Technologies Ltd., dated June 9, 2022 (Filed With SEC on August 9, 2022)
- Form of Shareholder Lock-up Agreement (Filed With SEC on March 28, 2022)
- Form of Shareholder Undertaking (Filed With SEC on March 28, 2022)
- Securities Purchase Agreement, dated January 7, 2020, between the Company and Tyme (Filed With SEC on January 8, 2020)
- Amendment No. 1 to Stock Purchase Agreement, dated as of February 8, 2018 (Filed With SEC on February 14, 2018)
- CREDIT AGREEMENT dated as of January 26, 2017 among EAGLE PHARMACEUTICALS, INC. The Lenders Party Hereto and JPMORGAN CHASE BANK, N.A. as Administrative Agent JPMORGAN CHASE BANK,... (Filed With SEC on March 15, 2017)
- STOCK PURCHASE AGREEMENT BY AND AMONG EAGLE PHARMACEUTICALS, INC. (as Buyer), ARSIA THERAPEUTICS, LLC (the Seller), ARSIA THERAPEUTICS, INC. (the Company), AMY SCHULMAN (solely in... (Filed With SEC on November 14, 2016)
- 1,320,276 Shares Eagle Pharmaceuticals, Inc. Common Stock PURCHASE AGREEMENT (Filed With SEC on March 17, 2015)
- [ ] Shares Eagle Pharmaceuticals, Inc. Common Stock PURCHASE AGREEMENT (Filed With SEC on January 28, 2014)
- EAGLE PHARMACEUTICALS, INC. 2014 EMPLOYEE STOCK PURCHASE PLAN ADOPTED BY THE BOARD OF DIRECTORS: , 201 APPROVED BY THE STOCKHOLDERS: , 201 (Filed With SEC on January 22, 2014)
- EAGLE PHARMACEUTICALS, INC. THIRD AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on December 20, 2013)
